none

CUSTOM DENTISTRY CHECKS IN

01-08-2017
by 
in 

One year after the initial rush of popularity and media interest, Australia's own custom dentistry startup has come a long way. 

Though the media might have been quiet, the team at Oventus has been hard at work securing distribution rights and certifications for the gobal market. 

In their latest report, they reveal that they have partnered for global distribution with the world's largest dental prosthetic provider, Modern Dental Group.

The distribution plan is to be funded by the proceeds of their initial share placement, which raised $7 million AUD. 

"We are very pleased to have Modern Dental as our go to market partner and exclusive distributor in the US. Modern Dental has market leading positions in Europe and Australia, and a very strong presence in the US, servicing a quarter of all dentists, via its laboratory business Microdental," said Neil Anderson, CEO of Oventus.

"The manufacturing agreement with Modern Dental is also important, as it will enable us to scale up manufacturing for a global market, at a lower cost. Over the next few months we will be working closely with Modern Dental to put in place the systems, training and marketing to ready us to begin ramping up sales from the October quarter, with the US as the main area of focus initially." 

The company was initially working with the CSIRO from 2014 onwards to help create and test their product and, grow business.

Oventus, a Melbourne based company, was approached by the CSIRO in 2014 after dentist Chris Hart had an idea for a mouthguard that would help airflow bypass for any obstructions in a sleep apnoea sufferers airway.

Now, according to the report, it has made "significant progresss in the execution of its clinical trial program to advance the validation of its proprietary airway technology" in its appliance line, including:

  • A peer reviewed article on the O2Vent Mono has been accepted for publication by the Journal of Dental Sleep Medicine.
  • A Brisbane clinical trial assessing the value of mandibular advancement with the Oventus airway technology is fully recruited.
  • A Perth clinical trial examining the physiological effect of the Oventus airway is now underway.

As for the 3D-dentistry market as a whole, predictions show that the international market is ballooning, with revenue set to hit $3.7 billion by 2021.

Related news & editorials

  1. 13.12.2018
    13.12.2018
    by      In
    Optibelt reckons its low-stretch and maintenance-free Red Power 3 v-belt drives offer a range of advantages in heavy-duty applications. Crucially, the belts are designed so that once correctly tensioned the first time, they don’t require retensioning - a valuable saver of time and money.
    A major... Read More
  2. 13.12.2018
    13.12.2018
    by      In
    Exair’s has developed a fine-mesh nonwoven drum cover for use on 60 and 205 litre drums. The breathable material allows the air from an Exair Line Vac air-operated conveyor to circulate when moving material in or out of a drum. The drum cover prevents contamination of the material and keeps it... Read More
  3. 12.12.2018
    12.12.2018
    by      In
    With almost 40 years of experience in applications of incremental shaft encoders, Plant Control & Automation has developed a number of instruments for both testing and simulating these complex devices.
    Now the company has put all this expertise into one instrument: the EncoderLab is both an... Read More
  4. 11.12.2018
    11.12.2018
    by      In
    Wenglor has expanded its PNG smart generation of photoelectronic sensors, available in Australia from Treotham Automation. The range now comprises seven devices, including new compact 1P (50 x 50 x 20mm) and 1N (75 x 32.5 x 18mm) housings, all equipped with IO-Link 1.1 for Industry 4.0 integration... Read More